Technology
Products
Market
About us
News
Investor relations

Reports

Quarterly report January–March 2020

2019

2018

2016

2015

Year-end report 2015

Redwood Pharma

We develop ophthalmic drugs that address major medical needs. We focus on early-stage clinical development. Our long-term strategy is to enter into licence agreements with other drug companies who will in turn introduce products for the global market.

Welcome
Technology
Products
Market
About us
News
Investor relations
- Reports
- Presentations
Privacy Policy

Contact

Martin Vidaeus – CEO
070-232 29 29
martin.vidaeus@redwoodpharma.com

Ringvägen 100E, floor 9
118 60 Stockholm, Sweden